The FDA Should Not Allow Untested Peptides to Be Added Into Patients’ Medications

Дата публикации: 22-07-2026 00:00:00

The FDA is considering allowing seven unapproved peptides—substantially sourced through a Chinese gray market—to be used by U.S. compounding pharmacies, despite its own scientists warning against it. Approving them would legitimize unvetted foreign suppliers and undermine evidence-based drug regulation.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	FDA issues urgent warning for energy supplements sold in gas stations that contain dangerous illegal ingredients	0	6.09	20-04-2026
2	Eli Lilly targets alleged black market sales of its experimental GLP-1 drug	0	9.2	12-08-2026
3	FDA working to close 'GRAS' food-additive loophole: What is it?	0	12.78	10-08-2026
4	Senators Sponsor Bill Seeking Transparency on Foreign Control in U.S. Drug Supply Chain	0	8.21	17-07-2026
5	NYT: администрация США может ввести ограничения на поставки лекарств из Китая	0	0	10-09-2025
6	WSJ: из США в Китай для борьбы с коронавирусом отправляют препараты, не прошедшие проверки	0	0	28-01-2020
7	Senators question whether military pharmacy program is the best deal for beneficiaries	0	9.7	16-07-2026
8	"Известия": Россельхознадзор предложил ввести обязательную маркировку ветпрепаратов	0	0	22-02-2022
9	A new case of chip smuggling shows the limits of export controls	0	7	26-03-2026
10	REVEALED: US is collaborating with Chinese scientists to make bird flu strains more infectious and deadly as part of $1m project - despite fears similar tests unleashed Covid	0	6.46	16-02-2024

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.69. Источник: itif.org.